TY - JOUR AU - Liu, Chen-Hua AU - Kao, Jia-Horng PY - 2016 TI - Hepatocellular carcinoma recurrence after interferon-free direct acting antiviral treatment for chronic hepatitis C virus infection: fact or fiction? JF - Translational Cancer Research; Vol 5, Supplement 2 (August 22, 2016): Translational Cancer Research Y2 - 2016 KW - N2 - Hepatitis C virus (HCV) infection is the leading cause of cirrhosis, hepatic decompensation, hepatocellular carcinoma (HCC) and liver transplantation worldwide (1-3). Compared to HCV-infected patients who fail to achieve sustained virologic response (SVR) following interferon (IFN)-based antiviral therapies, those who achieve SVR have decreased long-term morbidity and mortality (4,5). In recent years, treating HCV with IFN-free direct acting antiviral agents (DAAs) has shown superb efficacy and safety and thus become the current standard of care for HCV infection. UR - https://tcr.amegroups.org/article/view/8773